Brad Hively - Nov 12, 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
By: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively
Stock symbol
TOI
Transactions as of
Nov 12, 2024
Transactions value $
$50,000
Form type
4
Date filed
12/2/2024, 04:04 PM
Previous filing
Jun 20, 2024
Next filing
Nov 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Other $0 -353K -49.08% $0.00 367K Nov 12, 2024 Direct F1
transaction TOI Common stock Purchase $42.5K +250K +68.17% $0.17 617K Nov 26, 2024 Direct F2
transaction TOI Common stock Purchase $7.5K +50K +8.11% $0.15 667K Dec 2, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 and $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.
F2 44,000 being restricted stock units that vest in full on the date of the Company's 2025 annual meeting of stockholders, subject to continued service with the Company through such vesting date.